Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Munich Re and, reportedly, Centene, have committed series C capital to Babylon Health, the developer of an artificial intelligence chatbot that diagnoses health issues.

The pharmaceutical firm will invest up to $11.7m through the fund, which is led by GCV Rising Star Paulo Braga.

The medical equipment provider has committed $14.5m to a medical technology-focused vehicle it will run in partnership with Sharewin Investment.

Novo, Partners Healthcare and Sham all contributed to a $74.6m round for Alizé Pharma 3, which is exploiting research from three US institutions.

Novo Ventures, Partners Innovation and Sham Innovation Santé all contributed to a $74.6m round for the third company to carry the Alizé Pharma moniker.

Wanxiang-backed Hello Heart, the developer of a home blood pressure-monitoring system, collected $12m in a round led by Khosla Ventures.

The venture firm has reached the final close for its latest life sciences fund, which features insurer Talanx among its LPs.

Utimco contributed to the fifth fund of Wellington Partners, which aims to back 15 to 20 life science businesses based in German-speaking countries.

Fosun Capital co-led a round for prostate cancer and gout drug developer Hinova Pharma, which had previously raised capital in 2014 and 2017.